These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4027117)

  • 1. Pharmacokinetics of primaquine in man. I. Studies of the absolute bioavailability and effects of dose size.
    Mihaly GW; Ward SA; Edwards G; Nicholl DD; Orme ML; Breckenridge AM
    Br J Clin Pharmacol; 1985 Jun; 19(6):745-50. PubMed ID: 4027117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite.
    Mihaly GW; Ward SA; Edwards G; Orme ML; Breckenridge AM
    Br J Clin Pharmacol; 1984 Apr; 17(4):441-6. PubMed ID: 6721990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disposition of primaquine in the isolated perfused rat liver. Effect of dose size.
    Ward SA; Mihaly GW; Nicholl DD; Edwards G; Breckenridge AM
    Drug Metab Dispos; 1985; 13(4):425-9. PubMed ID: 2863105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of primaquine in man. II. Comparison of acute vs chronic dosage in Thai subjects.
    Ward SA; Mihaly GW; Edwards G; Looareesuwan S; Phillips RE; Chanthavanich P; Warrell DA; Orme ML; Breckenridge AM
    Br J Clin Pharmacol; 1985 Jun; 19(6):751-5. PubMed ID: 4027118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of primaquine in patients with P. vivax malaria.
    Bhatia SC; Saraph YS; Revankar SN; Doshi KJ; Bharucha ED; Desai ND; Vaidya AB; Subrahmanyam D; Gupta KC; Satoskar RS
    Eur J Clin Pharmacol; 1986; 31(2):205-10. PubMed ID: 3542534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans.
    Ericsson H; Hamrén B; Bergstrand S; Elebring M; Fryklund L; Heijer M; Ohman KP
    Drug Metab Dispos; 2004 Sep; 32(9):923-9. PubMed ID: 15319332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the pharmacokinetics of primaquine.
    Fletcher KA; Evans DA; Gilles HM; Greaves J; Bunnag D; Harinasuta T
    Bull World Health Organ; 1981; 59(3):407-12. PubMed ID: 6976848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics and bioavailability of a tracer dose of [3H]-mebendazole in man.
    Dawson M; Braithwaite PA; Roberts MS; Watson TR
    Br J Clin Pharmacol; 1985 Jan; 19(1):79-86. PubMed ID: 3978023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of primaquine in healthy volunteers.
    Singhasivanon V; Sabcharoen A; Attanath P; Chongsuphajaisiddhi T; Diquet B; Turk P
    Southeast Asian J Trop Med Public Health; 1991 Dec; 22(4):527-33. PubMed ID: 1820639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ranitidine: single dose pharmacokinetics and absolute bioavailability in man.
    van Hecken AM; Tjandramaga TB; Mullie A; Verbesselt R; de Schepper PJ
    Br J Clin Pharmacol; 1982 Aug; 14(2):195-200. PubMed ID: 6125204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The disposition of primaquine in the isolated perfused rat liver. Stereoselective formation of the carboxylic acid metabolite.
    Nicholl DD; Edwards G; Ward SA; Orme ML; Breckenridge AM
    Biochem Pharmacol; 1987 Oct; 36(20):3365-9. PubMed ID: 3675598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects.
    Nave R; Bethke TD; van Marle SP; Zech K
    Clin Pharmacokinet; 2004; 43(7):479-86. PubMed ID: 15139796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers.
    Chang T; Black A; Dunky A; Wolf R; Sedman A; Latts J; Welling PG
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():49-56. PubMed ID: 3162901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro and In Vivo pharmacokinetic studies of bulaquine (analogue of primaquine), a novel antirelapse antimalarial, in rat, rabbit and monkey--highlighting species similarities and differences.
    Mehrotra N; Lal J; Puri SK; Madhusudanan KP; Gupta RC
    Biopharm Drug Dispos; 2007 Jul; 28(5):209-27. PubMed ID: 17410524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer.
    Bonate PL; Cunningham CC; Gaynon P; Jeha S; Kadota R; Lam GN; Razzouk B; Rytting M; Steinherz P; Weitman S
    Cancer Chemother Pharmacol; 2011 Apr; 67(4):875-90. PubMed ID: 20582417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and metabolism of 14C-levetiracetam, a new antiepileptic agent, in healthy volunteers.
    Strolin Benedetti M; Whomsley R; Nicolas JM; Young C; Baltes E
    Eur J Clin Pharmacol; 2003 Nov; 59(8-9):621-30. PubMed ID: 14530892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of sex effect on the pharmacokinetics of primaquine.
    Elmes NJ; Bennett SM; Abdalla H; Carthew TL; Edstein MD
    Am J Trop Med Hyg; 2006 Jun; 74(6):951-2. PubMed ID: 16760502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5.
    Mouly SJ; Matheny C; Paine MF; Smith G; Lamba J; Lamba V; Pusek SN; Schuetz EG; Stewart PW; Watkins PB
    Clin Pharmacol Ther; 2005 Dec; 78(6):605-18. PubMed ID: 16338276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cilostazol pharmacokinetics after single and multiple oral doses in healthy males and patients with intermittent claudication resulting from peripheral arterial disease.
    Bramer SL; Forbes WP; Mallikaarjun S
    Clin Pharmacokinet; 1999; 37 Suppl 2():1-11. PubMed ID: 10702882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.